Cardiac troponin-I (cTnI) in plasma is used daily as a biomarker indicative of the severity of myocardial damage in humans suffering cardiac ischemia due to coronary artery disease, commonly referred to as “heart attacks”. The gene discussed is TNNI3; the disease is coronary artery disorder.